Overview
Mark Kachner represents clients in complex, high-stakes intellectual property and competition disputes. He has extensive experience in patent and trade secret disputes with an emphasis on remedies. He has also tried cases involving copyright, trademark, trade dress, breach of contract, and other business torts. He regularly counsels corporations to translate the value of intellectual property rights into winning trial strategies. With two decades of experience, Mr. Kachner has advocated for clients in courtrooms across the country in a variety of industries, including medical device, pharmaceuticals, and consumer electronics.
Recently, Mr. Kachner was part of the trial team that secured $634 million in damages in a jury trial against Apple. Mr. Kachner has also secured a preliminary injunction in a trade secret dispute that was upheld by the Federal Circuit and successfully stopped an international competitor from entering the U.S. market.
With his litigation and technical expertise, Mr. Kachner masters sophisticated technologies and navigates competitive legal issues facing technology companies. Mr. Kachner also excels at counseling clients in preparation for litigation and helps resolve business disputes to avoid litigation where possible.
Education
- University of Southern California - Gould School of Law (USC) (J.D., 2004)
- University of California - Los Angeles (UCLA) (B.S. Chemical Engineering, 2001)
Affiliations
- Board of Governors – Association of Business Trial Lawyers
- Los Angeles Intellectual Property Law Association
Representative Experience
Masimo Corp. et al. v. Apple, Inc., (C.D. Cal.)
Represents Masimo against Apple in a multi-jurisdictional dispute, including the Central District of California (CD Cal), District of Delaware (D. Del), and International Trade Commission (ITC). Mr. Kachner worked with Masimo’s witnesses, and technical and economic experts, to build the strategy to enforce Masimo’s patent and trade secret rights. In the CD Cal case, after an eight-day trial, the jury found the Apple Watch infringed Masimo’s patent and awarded more than $634 million in damages.
Masimo Corp. v. Philips Electronics North America Corp. and Philips Medizin Systeme Boblingen GmbH. (D. Del.).
Represented Masimo in a multi-phase patent and antitrust litigation involving pulse oximetry. In the first phase, after a three-week trial, the jury found Philips infringed Masimo’s pulse oximetry technology and awarded more than $466 million. The jury also rejected Philips’ counter-infringement claims rejected their request for $169 million. The case settled during a second phase involving related technology and antitrust claims. Philips agreed to pay Masimo $300 million and enter a multi-year business partnership. Mr. Kachner then helped Masimo successfully enforce the settlement agreement in court securing an order requiring Philips to honor its obligations.
Masimo Corp. et al. v. True Wearables, Inc., Case No. 8:18-cv-02001 (C.D. Cal.), aff’d, 2022 WL 205485 (Fed. Cir. 2022)
Represented Masimo in a complex intellectual property case against a former executive. Mr. Kachner led the effort to secure a preliminary injunction barring the defendants from further using Masimo’s trade secrets and requiring that they prevent publishing Masimo’s confidential information in numerous patent applications. The Federal Circuit upheld the injunction in an interlocutory appeal. Mr. Kachner was then part of the trial team that secured a ruling that the former executive misappropriated trade secrets, breached his fiduciary duty, and violated his employment agreements. The Court enjoined sales of True Wearables’ products that contained Masimo’s trade secret technology and ordered the defendants to abandon patent applications containing Masimo trade secrets.
Masimo Corp. v. Shenzhen Mindray Bio-Medical Tech. Co. Ltd. and Mindray DS USA (C.D. Cal.)
Represented Masimo in patent, antitrust, and contract litigation. Mr. Kachner had a primary role developing Masimo’s strategy to enforce its patent and breach of contract claims. The case settled shortly before trial, with Mindray agreed to pay Masimo $25 million, and enter a favorable business arrangement whereby Mindray would purchase all pulse oximetry products in the U.S. and Canada from Masimo for more than a decade.
Oasis Medical v. Biocia Inc. (C.D. Cal)
Mr. Kachner led litigation against Biocia Inc. to enforce Oasis’s exclusive U.S. rights to certain OTC eye care technology. Secured a preliminary injunction barring the defendants from entering the U.S. market to sell competing technology using Oasis’s exclusive technology. Mr. Kachner then led his team through fact and expert discovery, and defeated summary judgment on all claims. Case resolved prior to trial.
Mr. Kachner continues to advise Oasis on its patent and trademark portfolio and guides Oasis on various competitive business matters, involving complex intellectual property and regulatory issues, across their range of eye care technologies and products.
3M v. Kerr (D. Del).
Represented Kerr to defend against claims of patent infringement involving dental composite technology. Case resolved prior to trial.
Environmental Construction Group v. Gutierrez (C.D. Cal)
Represented ECG in trade secret dispute involving multiple former employees taking highly confidential financial information to a competitor. Following discovery, Mr. Kachner helped secure a favorable settlement.
SmileDirectClub, LLC v. Donovan W. Berkely (C.D. Cal)
Represented Mr. Berkely to assert trademark rights and registrations and defend against claims of fraud on the trademark office. Mr. Kachner secured a partial dismissal on the pleadings, developed the case strategy, and secured a favorable settlement.
News & Insights
Articles
Co-author, “What’s Next For Foreign Patent Damages?” Law360, July 2, 2018
Co-author, “Be careful what you write: attorney-client privilege for international businesses,” International Litigation News, Newsletter of the International Bar Association Legal Practice Division, May 2012
“Patent suits: Inconsistent application of attorney-client privilege”, Los Angeles Daily Journal, February 28, 2012
“Targeting ISPs in the Enforcement of Intellectual Property Rights”, Los Angeles Lawyer, December 2009
Litigation Blog
- Factual Stipulations May Simplify Discovery, but Also Help Plaintiff Navigate Difficult Issues of Fact and Law
- Not a Cowboy Claim Construction, University of Wyoming’s Patent Adequately Defined Claim Term
- Skinny Labelling on Generic Drugs Does Not Avoid Induced Infringement of Patents Covering Non-Indicated Uses
- Limiting Terms in Preamble May Render Entire Preamble Limiting
- Government’s Pre-Litigation Conduct Cannot Justify a Court of Claims Fee Award
- Claims Covering Human Engineering That Exploits a Naturally-Occurring Phenomenon Are Patent Eligible
- The Risks of Overbroad Motions to Seal
- Courts Have No Jurisdiction Over Challenge to PTO Action Before Final Agency Decision
- Standing to Appeal in IPR Remains Even After Divesting Accused Products
- An Invention That Changes the Normal Operation of a System Is Not Abstract Under § 101
- $5 Million Attorneys’ Fee Award Affirmed Because Government’s Litigation Position Not Substantially Justified
- Infringement Need Not Be Ex Ante Determinable for Claim to Be Definite
- PTAB Must Give Notice and Opportunity to Respond When Raising Its Own Theory of Unpatentability
- Attorneys and Clients Behaving Badly – Deliberately Withheld Offer for Sale Is Inequitable Conduct
- Schrader Hit With $31 Million Patent Verdict Over Tire Pressure Sensors
- Wells Fargo Twice Found Guilty of Willfully Infringing Patents on Remote Check Depositing Technology
- Prior Art Disclosing Partially Overlapping Temperature Range Is Enough to Establish Prima Facie Case of Anticipation and Obviousness
- Integration Clause Does Not Necessarily Extinguish Prior Agreement on Same Patent
- No Appeal of PTAB’s Final Decision by Appealing a District Court’s Adoption of That Decision
- Safe Harbor Defense Under 35 U.S.C. §271(e)(1) Requires That the Accused Activity Is Solely for Uses Reasonably Related to Submitting Information to the FDA
- Defendant Awarded Attorney Fees After NPE Dismissed Frivolous Case with Prejudice
- North Carolina Jury Finds Dubose Strapping Inc. Liable for Willful Patent Infringement
Speeches & Seminars
Moderator – LAIPLA Washington in the West – Patent Damages Trends—Trial to Appeal (January 2026)
Speaker – “Patent Damages,” LAIPLA Spring Seminar (May 2025)
Speaker – “Blocking Patents: Impact of Acorda Therapeutics on Obviousness Analysis,” Strafford Webinar (January 2019)
Moderator – World Intellectual Property Day, Presentation to UCLA Engineering Society (April 2017)
“Lost Profits and Patent Damages – Lessons Learned from Masimo v. Philips” (with Greg Pinsonneault), Presentation to California Society of CPAs, Economic Damages Section Meeting (February 2017)
“Reasonable and Non-Discriminatory Royalties in Standards Essential Patent Litigation” (with Matt Lynde and Jeff Kichaven), Presentation to Beverly Hills Bar Association, (November 2015)